Surveillance of Summer Febrile Syndromes of Viral Origin in South of France
NCT ID: NCT00842166
Last Updated: 2014-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2009-02-28
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Effectiveness of a Diagnostic Kit in the Etiological Diagnosis of Fevers of the Traveler
NCT02827175
Evaluation of the DPP II Assay in Laos
NCT04299607
MULTIple Doses of IPTi Proposal: a Lifesaving High Yield Intervention
NCT05085340
Universal Versus Conditional Three-day Follow-up Visit for Children With Unclassified Fever
NCT02926625
Prevalence and Incidence of Lassa Virus Infection in Southern Mali
NCT03783143
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BLOOD DRAW
specific interview, sequential blood collection to allow virus isolation, molecular and serological diagnostics in patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Affiliated with a mode of social security
* After obtaining free and informed of the written assent
Exclusion Criteria
* Expectant mother
* Subject taking part in another clinical trial or in period of exclusion of a preceding clinical trial infectious
* Pathology of body requiring a specific treatment
* Discovered after inclusion d' a pregnancy
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
REMI CHARREL
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique Hopitaux De Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service des Maladies Infectieuses et Tropicales de l'Hôpital Nord, AP-HM
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-A00793-52
Identifier Type: -
Identifier Source: secondary_id
2008 19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.